2007 AMENDMENTS TO THE NATIONAL ACADEMIES' GUIDELINES FOR HUMAN EMBRYONIC STEM CELL RESEARCH (PB)

2008 AMENDMENTS TO THE NATIONAL ACADEMIES' GUIDELINES FOR HUMAN EMBRYONIC STEM CELL RESEARCH (PB)

A READY AND RESILIENT WORKFORCE FOR THE DEPARTMENT OF HOMELAND SECURITY (PB)

A REVIEW OF NASA HUMAN RESEARCH PROGRAM'S SCIENTIFIC MERIT ASSESSMENT PROCESSES (PB)

A REVIEW OF THE HHS FAMILY PLANNING PROGRAM (PB)

A RISK REDUCTION STRATEGY FOR HUMAN EXPLORATION OF SPACE (PB)

ACCELERATING THE DEVELOPMENT OF BIOMARKERS FOR DRUG SAFETY (PB)

ACCELERATING THE DEVELOPMENT OF NEW DRUGS AND DIAGNOSTICS (PB)

ADDRESSING THE BARRIERS TO PEDIATRIC DRUG DEVELOPMENT (PB)

ADVANCING NUCLEAR MEDICINE THROUGH INNOVATION (PB)

ADVANCING REGULATORY SCIENCE FOR MEDICAL COUNTERMEASURE DEVELOPMENT (PB)

ADVANCING THE DISCIPLINE OF REGULATORY SCIENCE FOR MEDICAL PRODUCT DEVELOPMENT (PB)

ADVANCING WORKFORCE HEALTH AT THE DEPARTMENT OF HOMELAND SECURITY (PB)

ADVERSE DRUG EVENT REPORTING (PB)

ALZHEIMER'S DIAGNOSTIC GUIDELINE VALIDATION (PB)

APPLYING AN IMPLEMENTATION SCIENCE APPROACH TO GENOMIC MEDICINE (PB)

ASSESSING MEDICAL PREPAREDNESS TO RESPOND TO A TERRORIST NUCLEAR EVENT (PB)

ASSESSING THE IMPACT OF APPLICATIONS OF DIGITAL HEALTH RECORDS ON ALZHEIMER'S DISEASE RESEARCH (PB)

ASSESSING THE MEDICAL RISKS OF HUMAN OOCYTE DONATION FOR STEM CELL RESEARCH (PB)

ASSESSMENT OF THE NIOSH HEAD-AND-FACE ANTHROPOMETRIC SURVEY OF U.S. RESPIRATOR USERS (PB)

AUTISM AND THE ENVIRONMENT (PB)

BARRIERS TO INTEGRATING CRISIS STANDARDS OF CARE PRINCIPLES INTO INTERNATIONAL DISASTER RESPONSE PLANS (PB)

BEYOND THE HIPAA PRIVACY RULE (PB)

BIOWATCH AND PUBLIC HEALTH SURVEILLANCE (PB)

BIOWATCH PCR ASSAYS (PB)

BREAST CANCER AND THE ENVIRONMENT (PB)

BUILDING A NATIONAL FRAMEWORK FOR THE ESTABLISHMENT OF REGULATORY SCIENCE FOR DRUG DEVELOPMENT (PB)

BUILDING A RESILIENT WORKFORCE (PB)

CAFFEINE IN FOOD AND DIETARY SUPPLEMENTS (PB)

CANCER AND THE ENVIRONMENT (PB)

CERTIFYING PERSONAL PROTECTIVE TECHNOLOGIES (PB)

CHALLENGES AND OPPORTUNITIES IN USING RESIDUAL NEWBORN SCREENING SAMPLES FOR TRANSLATIONAL RESEARCH (PB)

CHALLENGES FOR THE FDA (PB)

CHARACTERIZING AND COMMUNICATING UNCERTAINTY IN THE ASSESSMENT OF BENEFITS AND RISKS OF PHARMACEUTICAL PRODUCTS (PB)

CHIMPANZEES IN BIOMEDICAL AND BEHAVIORAL RESEARCH (PB)

CNS CLINICAL TRIALS (PB)

CONFLICT OF INTEREST IN MEDICAL RESEARCH, EDUCATION, AND PRACTICE (HB)

CORD BLOOD (HB)

COUNTERING VIOLENT EXTREMISM THROUGH PUBLIC HEALTH PRACTICE (PB)

CRISIS STANDARDS OF CARE (HB)

CRISIS STANDARDS OF CARE (PB)

CRISIS STANDARDS OF CARE (PB)

DERIVING DRUG DISCOVERY VALUE FROM LARGE-SCALE GENETIC BIORESOURCES (PB)

DEVELOPING A 21ST CENTURY NEUROSCIENCE WORKFORCE (PB)

DEVELOPING A NATIONAL REGISTRY OF PHARMACOLOGIC AND BIOLOGIC CLINICAL TRIALS (PB)

DEVELOPING AND STRENGTHENING THE GLOBAL SUPPLY CHAIN FOR SECOND-LINE DRUGS FOR MULTIDRUG-RESISTANT TUBERCULOSIS (PB)

DEVELOPING MULTIMODAL THERAPIES FOR BRAIN DISORDERS (PB)

DIFFUSION AND USE OF GENOMIC INNOVATIONS IN HEALTH AND MEDICINE (PB)

DIRECT-TO-CONSUMER GENETIC TESTING (PB)

DISCUSSION FRAMEWORK FOR CLINICAL TRIAL DATA SHARING (PB)

DISPENSING MEDICAL COUNTERMEASURES FOR PUBLIC HEALTH EMERGENCIES (PB)

EARTH MATERIALS AND HEALTH (PB)

ENABLING DISCOVERY, DEVELOPMENT, AND TRANSLATION OF TREATMENTS FOR COGNITIVE DYSFUNCTION IN DEPRESSION (PB)

ENABLING PRECISION MEDICINE (PB)

ENABLING RAPID AND SUSTAINABLE PUBLIC HEALTH RESEARCH DURING DISASTERS (PB)

ENGAGING THE PUBLIC IN CRITICAL DISASTER PLANNING AND DECISION MAKING (PB)

ENHANCING BIOWATCH CAPABILITIES THROUGH TECHNOLOGY AND COLLABORATION (PB)

ENHANCING THE VITALITY OF THE NATIONAL INSTITUTES OF HEALTH (PB)

ENSURING ENVIRONMENTAL HEALTH IN POSTINDUSTRIAL CITIES (PB)

ENSURING SAFE FOODS AND MEDICAL PRODUCTS THROUGH STRONGER REGULATORY SYSTEMS ABROAD (PB)

ENVIRONMENTAL HEALTH INDICATORS (PB)

ENVISIONING A TRANSFORMED CLINICAL TRIALS ENTERPRISE IN THE UNITED STATES (PB)

EPILEPSY ACROSS THE SPECTRUM (PB)

ESTABLISHING PRECOMPETITIVE COLLABORATIONS TO STIMULATE GENOMICS-DRIVEN PRODUCT DEVELOPMENT (PB)

ETHICAL CONSIDERATIONS FOR RESEARCH INVOLVING PRISONERS (PB)

EVALUATING OCCUPATIONAL HEALTH AND SAFETY RESEARCH PROGRAMS (PB)

EVALUATION OF BIOMARKERS AND SURROGATE ENDPOINTS IN CHRONIC DISEASE (PB)

EXAMINING THE HEALTH DISPARITIES RESEARCH PLAN OF THE NATIONAL INSTITUTES OF HEALTH (PB)

EXPLORING CHALLENGES, PROGRESS, AND NEW MODELS FOR ENGAGING THE PUBLIC IN THE CLINICAL RESEARCH ENTERPRISE (PB)

EXPLORING THE STATE OF THE SCIENCE IN THE FIELD OF REGENERATIVE MEDICINE (PB)

FACING THE REALITY OF DRUG-RESISTANT TUBERCULOSIS IN INDIA (PB)

FINAL REPORT OF THE NATIONAL ACADEMIES' HUMAN EMBRYONIC STEM CELL RESEARCH ADVISORY COMMITTEE AND 2010 AMENDMENTS TO THE NATIONAL ACADEMIES' GUIDELINES FOR HUMAN EMBRYONIC STEM CELL RESEARCH (PB)

FINANCING LONG-TERM SERVICES AND SUPPORTS FOR INDIVIDUALS WITH DISABILITIES AND OLDER ADULTS (PB)

FOSTERING INDEPENDENCE, PARTICIPATION, AND HEALTHY AGING THROUGH TECHNOLOGY (PB)

FROM MOLECULES TO MINDS (PB)

FROM SOURCE WATER TO DRINKING WATER (PB)

FUTURE DIRECTIONS OF CREDENTIALING RESEARCH IN NURSING (PB)

FUTURE OPPORTUNITIES TO LEVERAGE THE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (PB)

GAIN-OF-FUNCTION RESEARCH (PB)

GENERATING EVIDENCE FOR GENOMIC DIAGNOSTIC TEST DEVELOPMENT (PB)

GENES, BEHAVIOR, AND THE SOCIAL ENVIRONMENT (PB)

GENOME-BASED DIAGNOSTICS (PB)

GENOME-BASED DIAGNOSTICS (PB)

GENOME-BASED THERAPEUTICS (PB)

GLOBAL CRISIS OF DRUG-RESISTANT TUBERCULOSIS AND LEADERSHIP OF CHINA AND THE BRICS (PB)

GLOBAL HEALTH RISK FRAMEWORK (PB)

GLOBAL HEALTH RISK FRAMEWORK (PB)

GLUTAMATE-RELATED BIOMARKERS IN DRUG DEVELOPMENT FOR DISORDERS OF THE NERVOUS SYSTEM (PB)

GUIDANCE FOR ESTABLISHING CRISIS STANDARDS OF CARE FOR USE IN DISASTER SITUATIONS (PB)

GUIDELINES FOR HUMAN EMBRYONIC STEM CELL RESEARCH (PB)

HEALTH AND THE ENVIRONMENT IN THE SOUTHEASTERN UNITED STATES (PB)

HEALTHY, RESILIENT, AND SUSTAINABLE COMMUNITIES AFTER DISASTERS (PB)

HEARING HEALTH CARE FOR ADULTS (PB)

HEARING LOSS RESEARCH AT NIOSH (PB)

IMPLICATIONS OF NANOTECHNOLOGY FOR ENVIRONMENTAL HEALTH RESEARCH (PB)

IMPROVING ACCESS TO ESSENTIAL MEDICINES FOR MENTAL, NEUROLOGICAL, AND SUBSTANCE USE DISORDERS IN SUB-SAHARAN AFRICA (PB)

IMPROVING AND ACCELERATING THERAPEUTIC DEVELOPMENT FOR NERVOUS SYSTEM DISORDERS (PB)

IMPROVING THE EFFICIENCY AND EFFECTIVENESS OF GENOMIC SCIENCE TRANSLATION (PB)

IMPROVING THE HEALTH, SAFETY, AND WELL-BEING OF YOUNG ADULTS (PB)

IMPROVING THE UTILITY AND TRANSLATION OF ANIMAL MODELS FOR NERVOUS SYSTEM DISORDERS (PB)

INCORPORATING OCCUPATIONAL INFORMATION IN ELECTRONIC HEALTH RECORDS (PB)

INFORMATION SHARING AND COLLABORATION (PB)

INNOVATION AND INVENTION IN MEDICAL DEVICES (PB)

INNOVATIONS IN SERVICE DELIVERY IN THE AGE OF GENOMICS (PB)

INTEGRATING CLINICAL RESEARCH INTO EPIDEMIC RESPONSE (PB)

INTEGRATING LARGE-SCALE GENOMIC INFORMATION INTO CLINICAL PRACTICE (PB)

INTEGRATING THE PATIENT AND CAREGIVER VOICE INTO SERIOUS ILLNESS CARE (PB)

INTEGRATION OF FDA AND NIOSH PROCESSES USED TO EVALUATE RESPIRATORY PROTECTIVE DEVICES FOR HEALTH CARE WORKERS (PB)

INTEGRITY IN SCIENTIFIC RESEARCH (HB)

INTEGRITY IN SCIENTIFIC RESEARCH (PB)

INTERNATIONAL ANIMAL RESEARCH REGULATIONS (PB)

INTERNATIONAL REGULATORY HARMONIZATION AMID GLOBALIZATION OF DRUG DEVELOPMENT (PB)

INVESTING IN THE HEALTH AND WELL-BEING OF YOUNG ADULTS (PB)

LARGE SIMPLE TRIALS AND KNOWLEDGE GENERATION IN A LEARNING HEALTH SYSTEM (PB)

MEDICAL COUNTERMEASURES DISPENSING (PB)

MEDICAL SURGE CAPACITY (PB)

MENTAL, NEUROLOGICAL, AND SUBSTANCE USE DISORDERS IN SUB-SAHARAN AFRICA (PB)

MILITARY MEDICAL ETHICS (PB)

MITOCHONDRIAL REPLACEMENT TECHNIQUES (PB)

NATIONWIDE RESPONSE ISSUES AFTER AN IMPROVISED NUCLEAR DEVICE ATTACK (PB)

NEURODEGENERATION (PB)

NEUROSCIENCE BIOMARKERS AND BIOSIGNATURES (PB)

NEUROSCIENCE TRIALS OF THE FUTURE (PB)

NEW FRONTIERS IN CONTRACEPTIVE RESEARCH (PB)

NIH EXTRAMURAL CENTER PROGRAMS (PB)

NON-INVASIVE NEUROMODULATION OF THE CENTRAL NERVOUS SYSTEM (PB)

OCCUPATIONAL HEALTH NURSES AND RESPIRATORY PROTECTION (PB)

OPPORTUNITIES TO ADDRESS CLINICAL RESEARCH WORKFORCE DIVERSITY NEEDS FOR 2010 (PB)

ORGAN DONATION (PB)

OVERSIGHT AND REVIEW OF CLINICAL GENE TRANSFER PROTOCOLS (PB)

PAIN MANAGEMENT AND THE OPIOID EPIDEMIC (PB)

PERSPECTIVES ON BIOMARKER AND SURROGATE ENDPOINT EVALUATION (PB)

POST-INCIDENT RECOVERY CONSIDERATIONS OF THE HEALTH CARE SERVICE DELIVERY INFRASTRUCTURE (PB)

PRELIMINARY CONSIDERATIONS REGARDING NASA'S BIOASTRONAUTICS CRITICAL PATH ROADMAP (PB)

PREPAREDNESS AND RESPONSE TO A RURAL MASS CASUALTY INCIDENT (PB)

PREPAREDNESS, RESPONSE, AND RECOVERY CONSIDERATIONS FOR CHILDREN AND FAMILIES (PB)

PREPARING FOR AN INFLUENZA PANDEMIC (PB)

PREPOSITIONING ANTIBIOTICS FOR ANTHRAX (PB)

PRESERVING PUBLIC TRUST (PB)

PRETERM BIRTH (HB)

PREVENTING COGNITIVE DECLINE AND DEMENTIA (PB)

PREVENTING TRANSMISSION OF PANDEMIC INFLUENZA AND OTHER VIRAL RESPIRATORY DISEASES (PB)

PROMISING AND BEST PRACTICES IN TOTAL WORKER HEALTH (PB)

PROVIDING SUSTAINABLE MENTAL AND NEUROLOGICAL HEALTH CARE IN GHANA AND KENYA (PB)

PUBLIC ENGAGEMENT AND CLINICAL TRIALS (PB)

PUBLIC ENGAGEMENT ON FACILITATING ACCESS TO ANTIVIRAL MEDICATIONS AND INFORMATION IN AN INFLUENZA PANDEMIC (PB)

RAPID MEDICAL COUNTERMEASURE RESPONSE TO INFECTIOUS DISEASES (PB)

RARE DISEASES AND ORPHAN PRODUCTS (PB)

REAL-WORLD EVIDENCE GENERATION AND EVALUATION OF THERAPEUTICS (PB)

REBUILDING THE UNITY OF HEALTH AND THE ENVIRONMENT (PB)

REFINING PROCESSES FOR THE CO-DEVELOPMENT OF GENOME-BASED THERAPEUTICS AND COMPANION DIAGNOSTIC TESTS (PB)

RELIEVING PAIN IN AMERICA (PB)

REUSABILITY OF FACEMASKS DURING AN INFLUENZA PANDEMIC (PB)

REVIEW OF NASA'S EVIDENCE REPORTS ON HUMAN HEALTH RISKS (PB)

REVIEW OF NASA'S EVIDENCE REPORTS ON HUMAN HEALTH RISKS (PB)

REVIEW OF NASA'S EVIDENCE REPORTS ON HUMAN HEALTH RISKS (PB)

REVIEW OF NASA'S LONGITUDINAL STUDY OF ASTRONAUT HEALTH (PB)

SAFE AND EFFECTIVE MEDICINES FOR CHILDREN (PB)

SAFE MEDICAL DEVICES FOR CHILDREN (HB)

SAFE WORK IN THE 21ST CENTURY (PB)

SAFE WORK IN THE 21ST CENTURY (PB)

SEX DIFFERENCES AND IMPLICATIONS FOR TRANSLATIONAL NEUROSCIENCE RESEARCH (PB)

SHARING CLINICAL RESEARCH DATA (PB)

SHARING CLINICAL TRIAL DATA (PB)

SLEEP DISORDERS AND SLEEP DEPRIVATION (HB)

SMALL CLINICAL TRIALS (PB)

STRATEGIES TO IMPROVE CARDIAC ARREST SURVIVAL (PB)

STRATEGIES TO LEVERAGE RESEARCH FUNDING (PB)

STRENGTHENING A WORKFORCE FOR INNOVATIVE REGULATORY SCIENCE IN THERAPEUTICS DEVELOPMENT (PB)

STRENGTHENING HUMAN RESOURCES THROUGH DEVELOPMENT OF CANDIDATE CORE COMPETENCIES FOR MENTAL, NEUROLOGICAL, AND SUBSTANCE USE DISORDERS IN SUB-SAHARAN AFRICA (PB)

SYSTEMS FOR RESEARCH AND EVALUATION FOR TRANSLATING GENOME-BASED DISCOVERIES FOR HEALTH (PB)

TECHNOLOGIES TO ENABLE AUTONOMOUS DETECTION FOR BIOWATCH (PB)

TESTOSTERONE AND AGING (PB)

THE 2009 H1N1 INFLUENZA VACCINATION CAMPAIGN (PB)

THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (PB)

THE CTSA PROGRAM AT NIH (PB)

THE ECONOMICS OF GENOMIC MEDICINE (PB)

THE EMERGING THREAT OF DRUG-RESISTANT TUBERCULOSIS IN SOUTHERN AFRICA (PB)

THE ETHICAL CONDUCT OF CLINICAL RESEARCH INVOLVING CHILDREN (HB)

THE FUTURE OF DISABILITY IN AMERICA (HB)

THE FUTURE OF HOME HEALTH CARE (PB)

THE NATION'S MEDICAL COUNTERMEASURE STOCKPILE (PB)

THE NEW PROFILE OF DRUG-RESISTANT TUBERCULOSIS IN RUSSIA (PB)

THE PERSONAL PROTECTIVE TECHNOLOGY PROGRAM AT NIOSH (PB)

THE PUBLIC HEALTH EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE (PB)

THE ROLE OF ENVIRONMENTAL HAZARDS IN PREMATURE BIRTH (PB)

THE USE AND EFFECTIVENESS OF POWERED AIR PURIFYING RESPIRATORS IN HEALTH CARE (PB)

THE VALUE OF GENETIC AND GENOMIC TECHNOLOGIES (PB)

THERAPEUTIC DEVELOPMENT IN THE ABSENCE OF PREDICTIVE ANIMAL MODELS OF NERVOUS SYSTEM DISORDERS (PB)

TRANSFORMING CLINICAL RESEARCH IN THE UNITED STATES (PB)

UNDERSTANDING THE BENEFITS AND RISKS OF PHARMACEUTICALS (PB)

UNEQUAL TREATMENT (HB)

UNEQUAL TREATMENT (PB)

VENTURE PHILANTHROPY STRATEGIES TO SUPPORT TRANSLATIONAL RESEARCH (PB)

WHEN CHILDREN DIE (HB)

WORKSHOP ON DISABILITY IN AMERICA (PB)